BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

218 related articles for article (PubMed ID: 22158041)

  • 1. A p27Kip1 mutant that does not inhibit CDK activity promotes centrosome amplification and micronucleation.
    Sharma SS; Ma L; Bagui TK; Forinash KD; Pledger WJ
    Oncogene; 2012 Aug; 31(35):3989-98. PubMed ID: 22158041
    [TBL] [Abstract][Full Text] [Related]  

  • 2. SCF(Cyclin F) controls centrosome homeostasis and mitotic fidelity through CP110 degradation.
    D'Angiolella V; Donato V; Vijayakumar S; Saraf A; Florens L; Washburn MP; Dynlacht B; Pagano M
    Nature; 2010 Jul; 466(7302):138-42. PubMed ID: 20596027
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Suppression of centrosome amplification after DNA damage depends on p27 accumulation.
    Sugihara E; Kanai M; Saito S; Nitta T; Toyoshima H; Nakayama K; Nakayama KI; Fukasawa K; Schwab M; Saya H; Miwa M
    Cancer Res; 2006 Apr; 66(8):4020-9. PubMed ID: 16618721
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Specific CP110 Phosphorylation Sites Mediate Anaphase Catastrophe after CDK2 Inhibition: Evidence for Cooperation with USP33 Knockdown.
    Hu S; Lu Y; Orr B; Godek K; Mustachio LM; Kawakami M; Sekula D; Compton DA; Freemantle S; Dmitrovsky E
    Mol Cancer Ther; 2015 Nov; 14(11):2576-85. PubMed ID: 26304236
    [TBL] [Abstract][Full Text] [Related]  

  • 5. USP33 regulates centrosome biogenesis via deubiquitination of the centriolar protein CP110.
    Li J; D'Angiolella V; Seeley ES; Kim S; Kobayashi T; Fu W; Campos EI; Pagano M; Dynlacht BD
    Nature; 2013 Mar; 495(7440):255-9. PubMed ID: 23486064
    [TBL] [Abstract][Full Text] [Related]  

  • 6. CP110, a cell cycle-dependent CDK substrate, regulates centrosome duplication in human cells.
    Chen Z; Indjeian VB; McManus M; Wang L; Dynlacht BD
    Dev Cell; 2002 Sep; 3(3):339-50. PubMed ID: 12361598
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Molecular mechanisms controlling the cell cycle: fundamental aspects and implications for oncology].
    Viallard JF; Lacombe F; Belloc F; Pellegrin JL; Reiffers J
    Cancer Radiother; 2001 Apr; 5(2):109-29. PubMed ID: 11355576
    [TBL] [Abstract][Full Text] [Related]  

  • 8. p27KIP1, an inhibitor of cyclin-dependent kinases.
    Koff A; Polyak K
    Prog Cell Cycle Res; 1995; 1():141-7. PubMed ID: 9552359
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cyclin E-CDK2 is a regulator of p27Kip1.
    Sheaff RJ; Groudine M; Gordon M; Roberts JM; Clurman BE
    Genes Dev; 1997 Jun; 11(11):1464-78. PubMed ID: 9192873
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Redistribution of the CDK inhibitor p27 between different cyclin.CDK complexes in the mouse fibroblast cell cycle and in cells arrested with lovastatin or ultraviolet irradiation.
    Poon RY; Toyoshima H; Hunter T
    Mol Biol Cell; 1995 Sep; 6(9):1197-213. PubMed ID: 8534916
    [TBL] [Abstract][Full Text] [Related]  

  • 11. CDK2 Inhibition Causes Anaphase Catastrophe in Lung Cancer through the Centrosomal Protein CP110.
    Hu S; Danilov AV; Godek K; Orr B; Tafe LJ; Rodriguez-Canales J; Behrens C; Mino B; Moran CA; Memoli VA; Mustachio LM; Galimberti F; Ravi S; DeCastro A; Lu Y; Sekula D; Andrew AS; Wistuba II; Freemantle S; Compton DA; Dmitrovsky E
    Cancer Res; 2015 May; 75(10):2029-38. PubMed ID: 25808870
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Formation of p27-CDK complexes during the human mitotic cell cycle.
    Soos TJ; Kiyokawa H; Yan JS; Rubin MS; Giordano A; DeBlasio A; Bottega S; Wong B; Mendelsohn J; Koff A
    Cell Growth Differ; 1996 Feb; 7(2):135-46. PubMed ID: 8822197
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cyclin-dependent kinase control of centrosome duplication.
    Lacey KR; Jackson PK; Stearns T
    Proc Natl Acad Sci U S A; 1999 Mar; 96(6):2817-22. PubMed ID: 10077594
    [TBL] [Abstract][Full Text] [Related]  

  • 14. RNAi of mitotic cyclins in Drosophila uncouples the nuclear and centrosome cycle.
    McCleland ML; O'Farrell PH
    Curr Biol; 2008 Feb; 18(4):245-54. PubMed ID: 18291653
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Targeted disruption of Skp2 results in accumulation of cyclin E and p27(Kip1), polyploidy and centrosome overduplication.
    Nakayama K; Nagahama H; Minamishima YA; Matsumoto M; Nakamichi I; Kitagawa K; Shirane M; Tsunematsu R; Tsukiyama T; Ishida N; Kitagawa M; Nakayama K; Hatakeyama S
    EMBO J; 2000 May; 19(9):2069-81. PubMed ID: 10790373
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Multi-step control of spindle pole body duplication by cyclin-dependent kinase.
    Haase SB; Winey M; Reed SI
    Nat Cell Biol; 2001 Jan; 3(1):38-42. PubMed ID: 11146624
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Differential modulation of G1 cyclins and the Cdk inhibitor p27kip1 by platelet-derived growth factor and plasma factors in density-arrested fibroblasts.
    Winston J; Dong F; Pledger WJ
    J Biol Chem; 1996 May; 271(19):11253-60. PubMed ID: 8626675
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Regulation of cyclin-dependent kinase 4 during adipogenesis involves switching of cyclin D subunits and concurrent binding of p18INK4c and p27Kip1.
    Phelps DE; Xiong Y
    Cell Growth Differ; 1998 Aug; 9(8):595-610. PubMed ID: 9716177
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Kip/Cip and Ink4 Cdk inhibitors cooperate to induce cell cycle arrest in response to TGF-beta.
    Reynisdóttir I; Polyak K; Iavarone A; Massagué J
    Genes Dev; 1995 Aug; 9(15):1831-45. PubMed ID: 7649471
    [TBL] [Abstract][Full Text] [Related]  

  • 20. TGF-beta 1 induces the cyclin-dependent kinase inhibitor p27Kip1 mRNA and protein in murine B cells.
    Kamesaki H; Nishizawa K; Michaud GY; Cossman J; Kiyono T
    J Immunol; 1998 Jan; 160(2):770-7. PubMed ID: 9551912
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.